Ipsen Logo

Ipsen | IPN - Profile, Filings, Stock Info & Investor Relations Data

Ipsen | IPN
Filings & Investor Relations Data
Login to Watchlist

Create a free account or log in.

Country
France
Founded
1929
Ipsen (IPN)

About Ipsen

Improving lives and health outcomes.

Ipsen’s vision is to be a leading global mid-size biopharmaceutical company, with a focus on transformative medicines in three key therapeutic areas: oncology, rare disease and neuroscience.

At Ipsen, we’re dedicated to improving people’s lives and health outcomes. Our 5,700 employees around the world are committed to tackling areas of high unmet medical need to improve the quality of life of patients and caregivers.

Employees

5,700

Market Presence

Worldwide

Headquarters

65 QUAI GEORGES GORSE
92100, BOULOGNE-BILLANCOURT
France

Company Video

Video thumbnail
Click to load video from YouTube

Ipsen (IPN)
Key Financial Data

AI-Powered Financial Insights Coming Soon

We are currently processing the filings for this company to provide automated financial statement analysis, key ratios, and risk summaries. Please check back later!

Unlock Full Company Insights & AI Chat

Create a free account or log in to add companies to your watchlist, access more data, and chat directly with filings using our AI assistant (as shown!).

Ipsen (IPN)
Filings & Annual Reports
Chat with AI, summarize, and extract data from processed filings! Look for the 'View & AI' button.

Quick Filters:

Advanced Filters

View all types
Filing Information Actions

Insider Trading Activity

N/A (Other)
Sell EUR 91,374.66 EUR 107.50 04.09.24
N/A (Other)
Buy EUR 51,916.20 EUR 103.83 27.02.24
N/A (Other)
Buy EUR 0.00 EUR 0.00 31.07.23

Ipsen (IPN)
Stock & Investor Information

ISINs

Showing 5 of 18
FR0010259150
FR0126774670
FR0126827171
FR0126866161
FR0126871757

LEI

549300M6SGDPB4Z94P11

Stock Exchange Listings

Euronext Paris

Stock Index Memberships

STOXX Europe 600

Primary Stock Exchange Listing

View Ipsen on main exchange

Industry Classification